ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Computer Learning May Help Women In Treatment Decision

October 30, 2009

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily

May 8, 1992

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Cancer Meetings Listed

April 18, 1997

Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week.

May 14, 2004